SCHEMBL14269554

SCHEMBL14269554

C/C(Br)=C/c1ccc(C(F)(F)F)cc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.46
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 4/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
LMNA P02545 2/20 0.42
BACE1 P56817 1/20 0.40
L3MBTL1 Q9Y468 4/20 0.39
RAB9A P51151 1/20 0.39
EPHX2 P34913 1/20 0.38
SCN4A P35499 1/20 0.38
MAPT P10636 3/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
GFER P55789 1/20 0.37
KMT2A Q03164 1/20 0.37
PTGS1 P23219 4/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4889898 0.86 ALDH1A1 (0.46) CFTRALDH1A1KDM4EPKMHPGD
SCHEMBL21864798 0.75 ALDH1A1 (0.42) CFTRALDH1A1KDM4EPKMHPGD
SCHEMBL14269607 0.73 ALDH1A1 (0.37) ALDH1A1PKMHPGDHSD17B10GAA
SCHEMBL19145485 0.73 ALDH1A1 (0.46) CFTRALDH1A1KDM4EPKMHPGD
SCHEMBL22359538 0.73 ALDH1A1 (0.46) CFTRALDH1A1KDM4EPKMHPGD
SCHEMBL5106918 0.73 ALDH1A1 (0.50) CFTRALDH1A1KDM4EPKMHPGD
SCHEMBL30996284 0.69 ALDH1A1 (0.46) CFTRALDH1A1KDM4EPKMHPGD
SCHEMBL8120980 0.69 ALDH1A1 (0.54) CFTRALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8120979 0.69 ALDH1A1 (0.54) CFTRALDH1A1KDM4EHPGDHSD17B10
SCHEMBL6170951 0.68 CFTR (0.55) CFTRALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039625-A1 Screening Methods LAUTENS MARK 2008-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039625-A1 Screening Methods CBR3, ZKSCAN2, CRBN CFTR 3976/4885ALDH1A1 2175/4885KDM4E 3829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.